Quick Answer
RIGEL PHARMACEUTICALS INC reported Net Income of $367.02 million for fiscal year 2025.
RIGEL PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $367.02M | +1999.1% |
| 2024 | $17.48M | +169.7% |
| 2023 | -$25.09M | +57.2% |
| 2022 | -$58.57M | -227.0% |
| 2021 | -$17.91M | +39.8% |
| 2020 | -$29.74M | +55.5% |
| 2019 | -$66.89M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.90M | +124.6% | -53.2% |
| June 30, 2025 | $59.61M | +5887.7% | +420.8% |
| March 31, 2025 | $11.45M | +238.8% | -7.8% |
| September 30, 2024 | $12.42M | +318.2% | +1305.9% |
| June 30, 2024 | -$1.03M | +84.4% | +87.5% |
| March 31, 2024 | -$8.25M | +39.1% | -44.9% |
| September 30, 2023 | -$5.69M | +70.1% | +13.8% |
| June 30, 2023 | -$6.60M | +51.1% | +51.2% |
- RIGEL PHARMACEUTICALS INC showed an increase of +1999.1% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, RIGEL PHARMACEUTICALS INC’s net income has grown by 648.7% (from -$66.89 million to $367.02 million).
- The most recent figure is from RIGEL PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: